Francesco De Rose

Company: Nuclidium

Job title: Head of Pharmaceutical Development

Seminars:

Designing Optimal First in Human Radiopharmaceutical Trials for Translational Success: Regulatory Considerations 2:00 pm

First-in-human radiopharmaceutical trials are critical for assessing the safety, pharmacokinetics, dosimetry, and preliminary efficacy of new radiopharmaceuticals. The design of these trials must be meticulous to ensure patient safety while gathering essential data. Key components include patient monitoring duration, dose toxicity assessment, and primary readouts. Join this workshop to: Uncover pre, during and post-treatment monitoring…Read more

day: Workshop C

Optimising Dosing in Translational Radiopharmaceutical Studies 11:30 am

Using dosimetry to help determine dosing Optimising treatment regimens Preclinical screening and computational modellingRead more

day: Day 2 - P&T Track AM